NOD2 and hepatocellular carcinoma: Therefore we test the effect of NOD2 on the response of HCC cells to chemotherapeutic drugs, and we showed that NOD2 could significantly increase the chemosensitivity of HCC cells to the most commonly used chemotherapeutic drugs, including sorafenib, lenvatinib and 5-FU.